Safety of Use of Russian Biosimilars of Interferon Beta-1b in the Treatment of Multiple Sclerosis: a Meta-analysis of Original Studies

Presently, an active search for  modern drugs for  the  treatment of multiple sclerosis is ongoing. Since  the  treatment with original drugs is expensive, therefore, the  development of local biosimilars is underway, which at a lower  cost should be effective and safe  as original ones. The aim of...

Full description

Bibliographic Details

Published in:	Bezopasnostʹ i risk farmakoterapii (Online) Vol. 7; no. 2; pp. 93 - 98
Main Authors:	Gudz, D. O., Krasnov, A. E., Mamleev, R. N., Kagirov, R. K., Maximov, M. L.
Format:	Journal Article
Language:	English Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products 16-06-2019
Subjects:	adverse drug reactions biosimilars interferon beta-1b meta-analysis multiple sclerosis therapeutic equivalence
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!